Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. - Wikidata - wikimedia - TriplyDB

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

http://www.wikidata.org/entity/Q30395101

about

Evaluation of a novel non-penetrating electrode for use in DNA vaccination An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin Direct transfection of dendritic cells in the epidermis after plasmid delivery enhanced by surface electroporation.Topical gene electrotransfer to the epidermis of hairless guinea pig by non-invasive multielectrode array.HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo Optimization of a plasma facilitated DNA delivery method.DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.Thermal Assisted In Vivo Gene Electrotransfer.Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.Electroporation delivery of DNA vaccines: prospects for success Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo Cancer vaccination by electro-gene-transfer.Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.Short noncoding DNA fragment improve efficiencies of in vivo electroporation-mediated gene transfer.Adipose tissue: a new target for electroporation-enhanced DNA vaccines.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.Electroporation-mediated gene delivery.

P2860

Q28740588-EBD36EF2-0207-460A-98A7-AF851D536608 Q30375785-889257DD-B4DF-455D-AEFD-4A5764737130 Q33586294-8A87B84F-E784-43BD-A6F0-DC4FBC0212C6 Q33723334-238BE3BF-15DA-46BB-8A88-5143DA880626 Q34719492-78BDA1D8-7C8B-4876-94BB-EC55A924BDE3 Q34981733-D4743942-9AFB-4021-91F6-6FE132EF4CB2 Q35082880-C04025A3-8E2E-4872-BFBA-51D3A4E9EE76 Q35138037-FAE821F6-10B0-4B44-9049-0286CB4DDC09 Q35655963-0BF931A6-C1CD-49C1-8AF7-BD240561CC81 Q35665191-396AA5BB-4E5B-4622-943D-906E7AA13F42 Q35826661-5E96F1E7-3A17-4EC4-ADEF-8A4DEFA53FD4 Q35826688-1B6D9B07-18D8-49DC-88E7-87FDD0E3BB89 Q35868091-035BA76B-8AE0-477B-940D-3532D6A28B57 Q35974557-D4E676E4-BE5D-47FF-A17D-2CAF032264C4 Q36053828-81BB3FC7-91DE-4EB5-AC45-2C95508E424A Q36228884-C0401F61-821E-4D7C-845A-848293E385EC Q36258203-A77AC6DA-36C7-4C41-9D8C-7B1CA168144E Q36694881-971D6F37-B105-4D9B-BC0C-C79900000AD7 Q36694887-E51330C6-5B57-45B6-870A-3D0C86290A6D Q36837548-834F95D5-C4C8-4889-820C-F8615C5C2B86 Q37277042-059A2FDC-BA4B-44E1-8EC4-698C892087A1 Q37530445-542FEB8E-7D06-4076-916D-B738E3F9FD59 Q37530466-427DDBD7-6F41-42B4-9BC5-3939B66CDD3B Q37550619-3F7965FD-F663-43BE-83E2-11A6EAF181DB Q37573037-893F0ACC-899F-4765-8CB7-80FCE4856DEC Q37870313-86C8A87E-E191-47BE-834C-EFF3F15BF348 Q37996192-85DB667C-447A-4E8C-8A9E-7F525B855A5C Q38143182-84B7304E-B5CE-4A32-9979-108ABE41B6EC Q38835118-1269FB01-E5C6-4B9B-9C55-B86737A1E462 Q44106189-7F29E810-916D-4F92-A032-DD2C273F7125 Q44225799-B3E89E0E-818B-459B-AEB8-A5B46C99E48A Q45874005-5699C7FD-D64F-4793-ABB8-53773957CC0D Q53272516-459D599B-0411-41CD-A1C9-FA47744C40DE Q53329637-4573BEC2-A967-46C2-9408-CA8794E1D66C

P2860

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

http://www.wikidata.org/entity/Q30395101

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Prototype development and prec ...... vasive electroporation device.

@ast

Prototype development and prec ...... vasive electroporation device.

@en

type

label

Prototype development and prec ...... vasive electroporation device.

@ast

Prototype development and prec ...... vasive electroporation device.

@en

prefLabel

Prototype development and prec ...... vasive electroporation device.

@ast

Prototype development and prec ...... vasive electroporation device.

@en

P1433

Q30395101-4EC63283-6D26-4696-9A9F-624278466510

P1476

Q30395101-1FBD67DF-D09F-46A4-BBA0-6B9E5B02257B

P2093

Q30395101-0964272A-254E-46C7-A45C-20FE4FCF3367

Q30395101-2483B5A6-B806-4A20-BBBC-E1976BF9064C

Q30395101-2BB8A2F9-8DCC-4A1A-98D5-99C2C1CBD2E6

Q30395101-376AF002-44CC-44BF-928B-5190901CB38C

Q30395101-66DD4E00-DD82-4686-8BB9-911563A46008

Q30395101-88112B10-A3A1-4EBB-9A64-F8B7ABCFC47F

Q30395101-98869009-FEBE-406D-9FE5-398283527DD4

Q30395101-988F5B01-8CC6-4B1B-9FD2-9DE7B0DF5971

Q30395101-B7473EBF-0AC8-4363-8C35-EF073883443C

Q30395101-C89976B9-72C9-460E-899C-1259BBB12231

P2860

Q30395101-11EFA937-C2A2-4991-AEAC-DC1710BC7ECC

Q30395101-14F8A744-A89B-4F33-95F0-98D64E19FD21

Q30395101-1539AAC9-A659-4C0F-B14E-CF884C52622E

Q30395101-2FC3998C-7CF8-459C-B50C-5E058A287370

Q30395101-36F480F6-2EFB-423E-A0BD-7DFA353D9ABB

Q30395101-39D55D60-3860-4DED-96D8-4FC963D7782D

Q30395101-4597A08E-9A88-43AA-BEB3-8ADFACF0D74F

Q30395101-56F2885A-6BF8-4F05-B950-02D18839FC3A

Q30395101-59FEF1CF-291E-4419-992F-06A562D341DD

Q30395101-6F32233E-9DDC-4F89-8388-2DF014F2EEEE

P2888

Q30395101-464A12E9-CBD4-4179-93A6-FC616567369C

P304

Q30395101-EA80F13A-7DEC-4D1F-B2A9-AF421344B242

P31

Q30395101-EDB4BF59-4979-48CD-843D-846D7255497E

P356

Q30395101-7BC03355-36E9-4824-9DB4-393F4254E8B7

P433

Q30395101-B7D2092E-E8F4-4A72-92B7-DEABFF9D3D1D

P478

Q30395101-5E47F443-AA88-4AF0-BD76-1A45976DC448

P50

Q30395101-10D5D238-F19F-49F6-BEFD-F5A3F78A8717

P577

Q30395101-5EE02473-E69A-4DFC-83EB-9FD32BD87822

P5875

Q30395101-F00ACE42-6F22-4F1D-AA2E-1843B370CDE6

P698

Q30395101-C749FC41-FFCF-4041-958F-503A2988F957

P921

Q30395101-DC19DAC3-C80A-4267-9137-BF74D967350C

P356

P1433

P1476

Prototype development and prec ...... nvasive electroporation device

@en

P2093

A Patel

http://www.w3.org/2001/XMLSchema#string

A S Khan

http://www.w3.org/2001/XMLSchema#string

D B Weiner

http://www.w3.org/2001/XMLSchema#string

F Lin

http://www.w3.org/2001/XMLSchema#string

G P Kobinger

http://www.w3.org/2001/XMLSchema#string

J McCoy

http://www.w3.org/2001/XMLSchema#string

J Soderholm

http://www.w3.org/2001/XMLSchema#string

J Yan

http://www.w3.org/2001/XMLSchema#string

K E Broderick

http://www.w3.org/2001/XMLSchema#string

M P Morrow

http://www.w3.org/2001/XMLSchema#string

P2860

Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens.

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.

Biochemistry of human skin--our brain on the outside.

Plasmid-based gene therapy of diabetes mellitus.

Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus.

Dendritic cells: biology of the skin.

Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.

P2888

P304

258-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2010.137

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Niranjan Y Sardesai

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47510557

http://www.w3.org/2001/XMLSchema#string

P698

20962869

http://www.w3.org/2001/XMLSchema#string

P921

electroporation